University of Kansas

University of Kansas

University of Kansas

Overview
Date Founded

1865

Headquarters

1502 Iowa Street,Lawrence, KS 66045-7576

Industries

Private Equity & Venture Capital

Company Description

The University of Kansas (KU) is a public research university and the largest university in the State of Kansas. KU campuses are located in Lawrence, Wichita, Overland Park, Salina, and Kansas City, Kansas, with the main campus located in Lawrence on Mount Oread, the highest location in Lawrence. The University was opened in 1866, under a charter granted by the Kansas Legislature in 1864.

Website

http://www.ku.edu

Contact Data
Trying to get in touch with decision makers at University of Kansas? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Targeted News Service
January 15, 2021
New University of Kansas Research Center to Map Clearer Pathways From Learning Outcomes to Employment Success
The Miami Herald
January 14, 2021
Kansas researchers working for more viable rural communities
Targeted News Service
January 14, 2021
University of Kansas Studies Show Breakfast Can Improve Basketball Shooting Performance
Targeted News Service
January 13, 2021
University of Kansas: New Bachelor of Science in Education, Elementary Education Prepares Educators to Lead Inclusive Classrooms
Targeted News Service
January 13, 2021
University of Kansas: Presidential Rhetoric Expert Can Comment on Biden Inaugural Speech

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
Irina Six

Owner

Jenny Mehmedovic

Owner

Penny Kellum

Owner

Darrell Brogdon

Owner

Brad Nachtigal

Owner

Myunghyun OH

Owner

Tamara Falicov

Owner

Brett Wedel

Owner

Herman Munczek

Owner

Marilyn Figuieras

Owner

Board of Directors
Karen Seaberg

Co-Owner at Long John Silver's LLC

Mike Powell

General Partner at Sofinnova Ventures, Inc.

Neal Sharma

Chief Executive Officer & Co-Founder at Digital Evolution Group LLC

Distinguished Alumni
See More
David G. Booth is now Founder & Executive Chairman at Dimensional Fund Advisors LP
Peter Alex Mallouk is now President & Chief Investment Officer at Creative Planning, Inc.
Peter C. Brown is now Founder at EPR Properties
Trending People
Manchester United Limited
'Our goals are not cancelled' - Olympic champions on motherhood and postponed Ga... - BBC
The National Guard
Photos: The Nation's Capital, Quiet And Guarded, Before Inauguration - npr.org
Democratic Party
Italy's embattled PM set to face two confidence votes - The Daily Telegraph (London)
Page Street Publishing Co.
T.I. Riddle's new book "Madness" is an intimate journey of the author's life as... - PR Newswire
Cable News Network, Inc.
China debuts train that can hit speeds of 620 kilometers per hour - CNN
Trending Organizations
Manchester United Limited
'Our goals are not cancelled' - Olympic champions on motherhood and postponed Ga... - BBC
The National Guard
Photos: The Nation's Capital, Quiet And Guarded, Before Inauguration - npr.org
Democratic Party
Italy's embattled PM set to face two confidence votes - The Daily Telegraph (London)
Page Street Publishing Co.
T.I. Riddle's new book "Madness" is an intimate journey of the author's life as... - PR Newswire
Cable News Network, Inc.
China debuts train that can hit speeds of 620 kilometers per hour - CNN
Paths to University of Kansas
Potential Connections via
Relationship Science
You
University of Kansas
Advisors & Consultants
Advisor
Ashley Deihr

Partner at Baker Tilly US LLP

Advisor
Martin Grenzebach

Chairman at Grenzebach Glier & Associates, Inc.

Consultant
Melinda Church

Senior Vice President at Grenzebach Glier & Associates, Inc.
Clients
Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

Orphazyme A/S

Orphazyme A/S engages in development of treatment for patients living with life-threatening and debilitating rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Mørkeberg Hinsby, Marja Jäättela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
Non-Profit Donations & Grants Received
$175K
12/31/2015
The G. Harold & Leila Y. Mathers Charitable Foundation

$8,750
02/28/2015
Brisley Scholarship Loan Fund

$175K
12/31/2014
The G. Harold & Leila Y. Mathers Charitable Foundation

Investments
Details Hidden
AstrumU, Inc.

AstrumU, Inc. designs and develops machine learning solutions to help students find careers. The firm offers AstrumU platform. The company was founded by Adam Wray in 2017 and is headquartered in Kirkland, WA.

Details Hidden
Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company which develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. The company designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas, and other solid tumors. It also develops two other clinical-stage drug candidates, DCC-3014 and rebastinib, as immuno-oncology kinase, inhibitors targeting the kinases CSF1R, and TIE2 kinas. The company was founded by Peter A. Petillo and Daniel L. Flynn in November 2003 and is headquartered in Waltham, MA.

Details Hidden
VasoGenix Pharmaceuticals, Inc.

Vasogenix Pharmaceuticals, Inc. develops cardiology drug products for acute treatment of life threatening ischemia associated with myocardial infarction and the chronic treatment of congestive heart failure. The company was founded in 2001 and is headquartered in Lenexa, KS.

Suppliers
SolarWinds Corp. IT Consulting & Services | Austin, TX

SolarWinds Corp. engages in the provision of information technology (IT)infrastructure management software. It provides network management, systems management, database management, IT security, IT helpdesk, and cloud services. The company was founded in 1999 and is headquartered in Austin, TX.

ImpediMed Ltd. Industrial Machinery & Manufacturing | Pinkenba, Australia

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. It operates through the Medical, and Test and Measurement segments. The Medical segment supplies non-invasive medical technology products and services to measure, monitor, and manage tissue composition and fluid status using bioimpedance spectroscopy. The Test and Measurement segment offers power precision testing and measuring equipment. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

Quanterix Corp. Biotechnology | Lexington, MA

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Awards & Honors
Rank #188
2010
The Chronicle of Philanthropy - Philanthropy 400
Sponsored by The Chronicle of Philanthropy
Rank #173
2009
The Chronicle of Philanthropy - Philanthropy 400
Sponsored by The Chronicle of Philanthropy

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University of Kansas. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University of Kansas's profile does not indicate a business or promotional relationship of any kind between RelSci and University of Kansas.